KLRS

Samsara BioCapital’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$30.6M	Hold	11,448,081	–	–	6.25%	4
2025 Q1	$91.9M	Buy	11,448,081 +11,365,745	+13,804%	+$91.3M	16.39%	2
2024 Q4	$34.6K	Hold	82,336	–	–	﹤0.01%	41
2024 Q3	$66.6K	Hold	82,336	–	–	0.01%	40
2024 Q2	$59.6K	Hold	82,336	–	–	0.01%	38
2024 Q1	$62.2K	Hold	82,336	–	–	0.01%	37
2023 Q4	$56K	Hold	82,336	–	–	0.01%	39
2023 Q3	$177K	Hold	82,336	–	–	0.05%	38
2023 Q2	$280K	Hold	82,336	–	–	0.05%	41
2023 Q1	$324K	Hold	82,336	–	–	0.07%	45
2022 Q4	$422K	Hold	82,336	–	–	0.09%	44
2022 Q3	$650K	Hold	82,336	–	–	0.15%	44
2022 Q2	$321K	Hold	82,336	–	–	0.09%	50
2022 Q1	$556K	Hold	82,336	–	–	0.14%	53
2021 Q4	$1.07M	Hold	82,336	–	–	0.21%	40
2021 Q3	$2.06M	Hold	82,336	–	–	0.32%	37
2021 Q2	$1.63M	Hold	82,336	–	–	0.2%	44
2021 Q1	$1.93M	Hold	82,336	–	–	0.36%	38
2020 Q4	$3.17K	Sell	82,336 -8,721	-10%	-$335	0.32%	31
2020 Q3	$2.5M	Buy	+91,057	New	+$2.5M	0.7%	24